Clinical Trial Update: DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass [NA]

View source ↗

Summary

DETOUR I, a clinical study of a percutaneous femoropopliteal bypass device by Endologix, has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• DETOUR I

Snippet

Sponsor: Endologix | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED | Results posted: 2025-05-23